HKU Scholars Hub: Browsing DSpace

Browsing by Author rp01466

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 59 to 78 of 297 < previous next >

Title	Author(s)	Issue Date
Editorial to “Palbociclib and letrozole in advanced breast cancer” Journal:Translational Cancer Research	Chiu, WYJ Kwok, G Yau, TCC Leung, R	2017
Efficacy and safety of every-2-weeks cetuximab combined with FOLFOX or FOLFIRI as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (mCRC): an Asia-Pacific nonrandomized phase II study (APEC) Proceeding/Conference:Journal of Clinical Oncology	Cheng, AL Cornelio, GH Shen, L Price, TJ Yang, TS Chung, IJ Dai, G Lin, JK Sharma, A Yeh, KH Ma, B Zaatar, A Guan, ZZ Masood, N Srimuninnimit, V Yau, TCC Sarholz, B Lim, RSC	2013
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial Journal:JAMA Oncology	Yau, TCC Kang, YK Kim, TY El-Khoueiry, AB Santoro, A Sangro, B Melero, I Kudo, M Hou, MM Matilla, A Tovoli, F Knox, JJ He, AR El-Rayes, BF Acosta-Rivera, M Lim, HY Neely, J Shen, Y Wisniewski, T Anderson, J Hsu, C	2020
Efficacy and safety of single agent sunitinib in treating Sorafenib Refractory Advanced Hepatocellular Carcinoma Patients: a prospective, open-label, phase II study Proceeding/Conference:Liver Cancer	Yau, TCC Leung, RCY Wong, HYH Chiu, JWY Chan, P Tang, YF Cheung, TT Pang, RWC Fan, ST Poon, RTP	2013
Efficacy and safety of single-agent sunitinib in treating advanced hepatocelluar carcinoma patients after sorafenib failure: a prospective, open-label, phase II study Proceeding/Conference:Annals of Oncology	Yau, TCC Leung, RCY Wong, H Chiu, J Chan, P Pang, RWC Fan, ST Poon, RTP	2011
Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocelluar carcinoma after sorafenib failure: a prospective, open-label, phase II study Proceeding/Conference:Journal of Clinical Oncology	Yau, T Leung, RC Wong, H Chiu, J Chan, P Pang, R Fan, ST Poon, RTP	2011
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis Journal:Asian Pacific Journal of Cancer Prevention	Chiu, Joanne Tang, Vikki Leung, Roland Wong, Hilda Chu, Kinwah Poon, Jensen Epstein, Richard John Yau, Thomas	2013
Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma Proceeding/Conference:Oncology	Yau, T Chan, P Wong, H Ng, KK Chok, KSH Cheung, TT Lam, V Epstein, RJ Fan, ST Poon, RTP	2007
Efficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinoma Proceeding/Conference:Journal of Clinical Oncology	Wong, H Yau, CC Yao, T Tang, V Chan, P Chiu, J Fan, ST Poon, R	2010
Efficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract) Proceeding/Conference:International Meeting Hepatocellular Carcinoma, IMHCC 2011	Yau, TCC Chan, P Cheung, FY Lee, AS Yau, TK Choo, SP Toh, HC Leung, AK Wong, JS Wong, S Lau, J Pang, RWC Fan, ST Poon, RTP	2011
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study Journal:Clinical Colorectal Cancer	Cheng, AL Cornelio, G Shen, L Price, T Yang, TS Chung, IJ Dai, GH Lin, JK Sharma, A Yeh, KH Ma, B Zaatar, A Guan, Z Masood, N Srimuninnimit, V Yau, TCC Gibbs, P Wang, X Doval, DC Seung-Taek, O Shim, BY Gorospe, C Wang, HM Sirachainan, E Hill, A Suh, KW Beier, F Chatterjee, S Lim, R	2017
Emerging Therapies for Advanced Pancreatic Cancer Patients Proceeding/Conference:International Association of Surgeons, Gastroenterologists and Oncologists (IASGO) World Congress 2014, Vienna, Austria	Yau, TCC	2014
Emerging Therapies for Advanced Pancreatic Cancer Patients Proceeding/Conference:Multi-specialty Medical Mega Conference, Hong Kong	Yau, TCC	2017
The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance Journal:PLoS ONE	Chow, Ariel Ka Man Ng, Lui Lam, Colin Siu Chi Wong, Sunny Kit Man Wan, Timothy Ming Hun Cheng, Nathan Shiu Man Yau, Thomas Chung Cheung Poon, Ronnie Tung Ping Pang, Roberta Wen Chi	2013
Enhanced metastatic potential of hepatocellular carcinoma cells with sorafenib resistance Proceeding/Conference:Hepatology International	Chow, AKM Lam, CSC Ng, L Wong, SKM Wan, TMH Cheng, NSM Cheng, T Yau, TCC Poon, RTP Pang, RWC	2013
Evidence of SIRT in HCC- Hong Kong Experience Proceeding/Conference:SIRTEX Satellite Tea Time symposium, Asia Oncology Summit	Yau, TCC	2013
Evolution of neoadjuvant chemotherapy in locally advanced HER2-positive breast cancer over 10 years in Hong Kong Proceeding/Conference:Annals of Oncology	Chiu, WYJ Leung, RCY Tang, YFV Cheuk, I Lo, J Wong, HYH Kwok, G Suen, TKD Yau, TCC Kwong, A	2015
Evolution of systemic therapy of advanced hepatocellular carcinoma Journal:World Journal of Gastroenterology	Yau, T Chan, P Epstein, R Poon, RT	2008
Evolving standard of care: a novel antiangiogenic agent for treating metastatic renal cell carcinoma Proceeding/Conference:Hong Kong Pharmacy Conference 2011	Yau, TCC	2011
Examining the Current evidence for Treatment of NET: Clinical Insights Proceeding/Conference:Philippine Society of Medical Oncology Annual Conference 2015	Yau, TCC	2015

Showing results 59 to 78 of 297 < previous next >